DUBLIN, Calif., April 8, 2008 /PRNewswire/ -- Microchip Biotechnologies, Inc. (MBI) is pleased to announce that the Canadian Centre for DNA Barcoding (CCDB), at the Biodiversity Institute of Ontario, University of Guelph, will be the first participant to join MBI's early access program for the Apollo 100 STAR System. The Apollo 100 STAR is the first fully automated and integrated system for DNA sample preparation for sequencing. The System incorporates MBI's MOV(TM) (Microscale-On-Chip-Valve) technology exclusively licensed from the University of California.
DNA sample preparation is a tedious and time consuming process performed prior to DNA sequencing. There are numerous manual stages that use costly reagents and are subject to human error. MBI's Apollo 100 STAR automatically performs DNA cycle sequencing and bead-based cleanup on microchips which significantly reduces labor, costly reagent consumption, and potential errors in sample processing.
"We are delighted that the Canadian Centre for DNA Barcoding has agreed to collaborate in our Apollo 100 STAR early access program. Their commitment to this program validates MBI's overall strategic goal to develop and market front-end sample preparation systems for life science and diagnostic solutions," said Stevan Jovanovich, Ph.D., President and CEO of MBI.
"We are excited about the prospects of using Apollo 100 STAR in our facility. MBI is focused on developing technologies that will significantly aid in DNA barcoding systems. CCDB is committed to adopt such advanced technologies and to aid in technology development particularly in partnership with the commercial sector," said Mehrdad Hajibabaei, Ph.D., Associate Director of CCDB.
About Microchip Biotechnologies
Microchip Biotechnologies, Inc. is an early-stage privately-held
company located in Dublin, California that is developing advanced
programmable fluidic sample preparation and analytical instrumentation for
|SOURCE Microchip Biotechnologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved